Showing 1 - 20 results of 25 for search 'M. S. Shamkhalova', query time: 0.04s
Refine Results
-
1
-
2
-
3
-
4
COVID-19 and kidneys by M. S. Shamkhalova, N. G. Mokrysheva, M. V. Shestakova
Published 2020-08-01Get full text
Article -
5
Sodium-glucose cotransporter 2 inhibitors as potential anticancer agents by E. R. Radkevich, A. S. Severina, M. S. Shamkhalova, M. V. Shestakova
Published 2025-05-01Get full text
Article -
6
-
7
-
8
-
9
Hyponatremia as acute adrenal insufficiency in patients with type 1 diabetes mellitus and kidney transplantation cause end-stage chronic kidney disease by I. S. Khagabanova, O. K. Vikulova, M. S. Shamkhalova, E. A. Pigarova, S. A. Martinov, V. Y. Kalashnikov
Published 2024-07-01Get full text
Article -
10
Oral semaglutide: the innovation in type 2 diabetes management by M. V. Shestakova, M. Sh. Shamkhalova, G. R. Galstyan, L. A. Ruyatkina, L. A. Suplotova
Published 2021-09-01Get full text
Article -
11
A simultaneous pancreas-kidney transplantation for type 1 diabetes mellitus after a long-term of receiving hemodialysis renal replacement therapy. Clinical сase by R. Kh. Salimkhanov, M. I. Yevloyeva, A. S. Severina, M. Sh. Shamkhalova, N. P. Trubitsyna, Y. G. Moysyuk
Published 2022-05-01Get full text
Article -
12
Trends in the epidemiology of chronic kidney disease in patients with diabetes in Russian Federation according to the Federal diabetes register (2010–2022) by M. S. Shamkhalova, O. K. Vikulova, A. V. Zheleznyakova, M. A. Isakov, M. V. Shestakova, I. I. Dedov, N. G. Mokrysheva
Published 2023-11-01Get full text
Article -
13
-
14
Markers of inflammation, fibrosis, endothelial dysfunction, and podocytopathy in patients with long-term type 1 diabetes mellitus by M. I. Yevloyeva, M. S. Arutyunova, L. V. Nikankina, A. I. Sleptsova, O. N. Naumenko, Z. T. Zuraeva, A. S. Severina, N. P. Trubitsyna, M. S. Shamkhalova, М. V. Shestakova
Published 2025-05-01Get full text
Article -
15
-
16
The advisory board resolution on the use of sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide 1 receptor agonists in type 2 diabetes by M. B. Antsiferov, G. R. Galstyan, T. Yu. Demidova, A. V. Zilov, T. N. Markova, А. M. Mkrtumyan, N. A. Petunina, I. S. Khalimov, M. S. Shamkhalova, M. V. Shestakova
Published 2023-05-01Get full text
Article -
17
The structure of mineral and bone disorders in patients with сhronic kidney disease of the 5th dialysis stage, taking into account the presence or absence of a diagnosis of type 1... by I. S. Maganeva, A. K. Eremkina, A. P. Miliutina, S. A. Martynov, A. S. Severina, R. H. Salimkhanov, M. I. Evloeva, M. Sh. Shamkhalova, M. V. Shestakova, N. G. Mokrysheva
Published 2023-01-01Get full text
Article -
18
Chronic kidney disease in patients with diabetes mellitus: new challenges by M. S. Shamkhalova, O. Y. Sukhareva, S. A. Martynov, A. S. Severina, O. K. Vikulova, N. P. Trubitsyna, O. N. Naumenko, N. V. Zaytseva, M. V. Shestakova, I. I. Dedov, N. G. Mokrysheva
Published 2025-02-01Get full text
Article -
19
The role of canagliflozin in the prevention of stroke and chronic kidney disease in patients with type 2 diabetes mellitus: an expert council resolution by M. V. Shestakova, G. R. Galstyan, E. N. Grineva, A. V. Zilov, T. Yu. Demidova, A. M. Mkrtumyan, N. A. Petunina, L. A. Ruyatkina, O. Y. Sukhareva, L. A. Suplotova, M. S. Shamkhalova
Published 2023-11-01Get full text
Article -
20
Prospects of finerenone use in Russian population of patients with chronic kidney disease and type 2 diabetes. Resolution of multidisciplinary. Advisory board by M. V. Shestakova, V. A. Dobronravov, A. S. Ametov, M. B. Antsiferov, M. M. Batyushin, I. N. Bobkova, G. R. Galstyan, T. Y. Demidova, V. V. Klimontov, A. M. Mkrtumyan, N. A. Petunina, E. I. Prokopenko, N. V. Chebotareva, M. S. Shamkhalova
Published 2023-11-01Get full text
Article